[Skip to Content]
[Skip to Content Landing]
November 27, 1972

Special Award

JAMA. 1972;222(9):1160-1161. doi:10.1001/jama.1972.03210090040010

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Dr. Zubrod has led, since 1955, the national cancer chemotherapy program that is outstanding in the world today. This program accelerated and enlarged the discovery, testing, and application of new cancer drugs and developed methods to cure and control some cancers not effectively treated in the past.

Today more than 1 million Americans are receiving treatment for cancer. About 340,000 people will die this year from this disease, the second largest cause of death in the United States.

The evaluation of cancer chemotherapy is too complex to be successfully conducted by only one investigator or institution. The advances in the use of anticancer drugs are the result of an intensive coordinated effort of many basic scientists, contracting laboratories, pharmaceutical companies, and clinical investigators.

As intramural director of the National Cancer Institute, chairman of the Leukemia Task Force, scientific director of chemotherapy and now director, Division of Cancer Treatment of the